Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan.
Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan.
Tissue Eng Regen Med. 2022 Dec;19(6):1295-1310. doi: 10.1007/s13770-022-00490-0. Epub 2022 Nov 8.
Extracellular vesicles (EVs) are derived from internal cellular compartments, and have potential as a diagnostic and therapeutic tool in degenerative disease associated with aging. Mesenchymal stem cells (MSCs) have become a promising tool for functional EVs production. This study investigated the efficacy of EVs and its effect on differentiation capacity.
The characteristics of MSCs were evaluated by flow cytometry and stem cell differentiation analysis, and a production mode of functional EVs was scaled from MSCs. The concentration and size of EVs were quantitated by Nanoparticle Tracking Analysis (NTA). Western blot analysis was used to assess the protein expression of exosome-specific markers. The effects of MSC-derived EVs were assessed by chondrogenic and adipogenic differentiation analyses and histological observation.
The range of the particle size of adipose-derived stem cells (ADSCs)- and Wharton's jelly -MSCs-derived EVs were from 130 to 150 nm as measured by NTA, which showed positive expression of exosomal markers. The chondrogenic induction ability was weakened in the absence of EVs in vitro. Interestingly, after EV administration, type II collagen, a major component in the cartilage extracellular matrix, was upregulated compared to the EV-free condition. Moreover, EVs decreased the lipid accumulation rate during adipogenic induction.
The results indicated that the production model could facilitate production of effective EVs and further demonstrated the role of MSC-derived EVs in cell differentiation. MSC-derived EVs could be successfully used in cell-free therapy to guide chondrogenic differentiation of ADSC for future clinical applications in cartilage regeneration.
细胞外囊泡(EVs)源自细胞内区室,具有作为与衰老相关退行性疾病的诊断和治疗工具的潜力。间充质干细胞(MSCs)已成为生产功能性 EVs 的有前途的工具。本研究调查了 EV 的功效及其对分化能力的影响。
通过流式细胞术和干细胞分化分析评估 MSC 的特征,并从 MSC 中规模化生产功能性 EVs。通过纳米颗粒跟踪分析(NTA)定量 EV 的浓度和大小。使用 Western blot 分析评估外泌体特异性标志物的蛋白表达。通过软骨和成脂分化分析和组织学观察评估 MSC 衍生 EV 的作用。
NTA 测量的脂肪来源干细胞(ADSCs)和 Wharton 胶 MSC 衍生 EV 的粒径范围为 130-150nm,显示出外泌体标志物的阳性表达。在体外缺乏 EV 的情况下,软骨诱导能力减弱。有趣的是,在给予 EV 后,与无 EV 条件相比,软骨细胞外基质的主要成分 II 型胶原上调。此外,EV 降低了成脂诱导期间的脂质积累率。
结果表明,该生产模型可以促进有效 EV 的生产,并进一步证明 MSC 衍生 EV 在细胞分化中的作用。MSC 衍生 EV 可成功用于无细胞治疗,以指导 ADSC 的软骨分化,为未来软骨再生的临床应用提供帮助。